Gilead single tablet regimen of Bictegravir, Lenacapavir for HIV-1 meets primary endpoint in Phase 3 trial Written By Ruchika Sharma18 Nov 2025 12:30 PM ISTFoster City: Gilead Sciences has announced positive topline results from the Phase 3 ARTISTRY-1 trial. The open-label trial evaluated the...
JnJ to acquire Halda Therapeutics for USD 3.05 billion Written By Ruchika Sharma18 Nov 2025 11:15 AM ISTNew Brunswick: Johnson & Johnson has announced that it has entered into a definitive agreement to acquire Halda Therapeutics OpCo, Inc., a...
CDSCO Panel Asks Pure and Cure Healthcare To Revise Phase III Protocol of Tapinarof Cream 1% for Adult Psoriasis Written By Susmita Roy17 Nov 2025 7:01 PM ISTNew Delhi: In response to the proposal submitted by Pure and Cure Healthcare, the Subject Expert Committee (SEC) on Dermatology and Allergy,...
Danish Lab Chief Held for Allegedly Supplying Fake Amoxycillin, Cefixime Under SVR Healthcare's Name Written By Parthika Patel17 Nov 2025 6:53 PM ISTAmbala: In a significant enforcement action exposing a dangerous counterfeit drug operation, the Paonta Sahib police have arrested Aniketh Jain, owner...
Himachal Pharma Firm Partner Arrested for Fake Levocetirizine, Pregabalin Production Written By Parthika Patel17 Nov 2025 6:43 PM ISTBaddi: In a major blow to the counterfeit drug network operating in the Baddi industrial zone, the Himachal Pradesh State Drugs Control Administration...
Pfizer cuts BioNTech stake by 54.7 percent Written By Ruchika Sharma17 Nov 2025 5:21 PM ISTPfizer has sold a significant portion of its stake in German drugmaker BioNTech SE, a more than five years after the two companies teamed up to...
Intas Pharma appoints Mithrasekhar Reddy Gundre as Deputy General Manager - Downstream Processing Laboratory Written By Ruchika Sharma17 Nov 2025 4:30 PM ISTAhmedabad: Intas Pharma has announced the appointment of Mithrasekhar Reddy Gundre as Deputy General Manager - Downstream Processing Laboratory at the...
Biocon expects 50 percent drop in costs for developing complex biosimilars: Top executive Written By Ruchika Sharma17 Nov 2025 3:46 PM ISTBiocon is gearing up for a major lift in its biosimilars business, expecting development costs to drop by nearly 50 percent after the US proposed...
Novartis declares positive results from phase III study for new malaria treatment Written By Ruchika Sharma17 Nov 2025 2:30 PM ISTBasel: Novartis has announced positive results from KALUMA, a Phase III study for new malaria treatment KLU156 (ganaplacide/lumefantrine, or...
Marksans Pharma UK arm gets MHRA nod for Mefenamic Acid Film-Coated Tablets Written By Ruchika Sharma17 Nov 2025 1:30 PM ISTMumbai: Marksans Pharma Limited has announced that its wholly owned subsidiary, Relonchem Limited in UK, has received Marketing Authorization...
Lupin secures S&P Global ESG Score of 91 for 2025 Written By Ruchika Sharma17 Nov 2025 12:34 PM ISTMumbai: Global pharma firm Lupin Limited has announced that it has achieved an S&P Global ESG Score of 91 for 2025, well above the...
Indian Pharmacopoeia Commission, Jharkhand State Pharmacy Council collaborate for promotion of rational use of medicines Written By Ruchika Sharma17 Nov 2025 11:30 AM ISTNew Delhi: The Indian Pharmacopoeia Commission (IPC), Ghaziabad, an autonomous institution under the Ministry of Health and Family Welfare,...
